Subscribe to RSS
DOI: 10.1055/s-0029-1224649
© Georg Thieme Verlag Stuttgart ˙ New York
Imperative and Elective Indications for Nephron-Sparing Surgery for Renal Tumors: Long-Term Oncological Follow-Up
Zwingende und elektive Indikationen für die organerhaltende Chirurgie von Nierentumoren: Onkologisches Langzeit-Follow-upPublication History
Publication Date:
21 January 2010 (online)
Abstract
Introduction: Nephron-sparing surgery (NSS) is mandatory for patients with renal tumors in both kidneys or in a solitary kidney in order to preserve renal function (imperative indication). NSS has also become the gold standard (elective indication) for small unilateral renal tumors (< 4 cm) with a normal contralateral kidney. We report the oncological long-term follow-up of NSS of our own series and discuss the results of the current literature. Patients and Methods: From 1979 until 2006, a total of 851 patients was treated at our institution by NSS. The mean tumor diameter was 3 cm (0.5–11 cm) for elective cases and 4.2 cm (1.2–11 cm) for imperative cases. The median follow-up for elective cases is 4.7 years (0.1–24.1 years) and imperative cases 8 years (0.1–25.8 years). Cancer-specific survival (CSS) and local recurrence-free survival (RFS) were estimated. Results: Estimated CSS at 5 and 10 years for elective indications were 98.5 % and 96.7 % and for imperative indications (solitary kidney) 89.6 % and 76 %. RFS after 5 and 10 years for elective indications were 98.3 % and 95.7 %; and for imperative indications (solitary kidney) 89.4 % and 79.9 %. Chronic renal failure requiring haemodialysis developed after NSS in a solitary kidney in nine patients (11.2 %). Conclusion: NSS can be performed with oncologically safe and good functional results in imperative indications. In elective indications the resectability of a tumour rather than size and location is the limiting factor.
Key words
renal cell carcinoma - nephron-sparing surgery - oncological outcome - elective indication - imperative indication - surgery - complications
References
- 1 Parkin D M, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55 74-108
- 2 Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J Clin. 2005; 55 10-30
- 3 Lam J S, Shvarts O, Leppert J T et al. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol. 2005; 173 1853-1862
- 4 Pantuck A J, Zisman A, Belldegrun A S. The changing natural history of renal cell carcinoma. J Urol. 2001; 166 1611-1623
- 5 Robson C J, Churchill B M, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol. 1969; 101 297-301
- 6 Wells S. Successful removal of two solid circumrenal tumours. Br Med J. 1888; 41 758
- 7 Vermooten V. Indications for conservative surgery in certain renal tumors: a study based on the growth patterns of clear cell carcinoma. J Urol. 1950; 64 200-208
- 8 Licht M R, Novick A C. Nephron sparing surgery for renal cell carcinoma. J Urol. 1993; 149 1-7
- 9 Clark P E, Schover L R, Uzzo R G et al. Quality of life and psychological adaptation following surgery for localized renal cell carcinoma: impact of the amount of remaining renal tissue. Urology. 2001; 57 252-256
- 10 Shinohara N, Harabayashi T, Sato S et al. Impact of nephron-sparing surgery on quality of life in patients with localized renal cell carcinoma. Eur Urol. 2001; 39 114-119
- 11 Uzzo R G, Novick A C. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol. 2001; 166 6-18
- 12 Lane B R, Novick A C. Nephron-sparing surgery. BJU Int. 2007; 99 1245-1250
- 13 Pahernik S, Gillitzer R, Thuroff J W. Surgical atlas. Cone / wedge resection of renal cell carcinoma. BJU Int. 2004; 93 639-654
- 14 Bazeed M A, Scharfe T, Becht E et al. Conservative surgery of renal cell carcinoma. Eur Urol. 1986; 12 238-243
- 15 Pahernik S, Roos F, Hampel C et al. Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience. J Urol. 2006; 175 2027-2031
- 16 Frank I, Blute M L, Cheville J C et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003; 170 2217-2220
- 17 Steinbach F, Stockle M, Muller S C et al. Conservative surgery of renal cell tumors in 140 patients: 21 years of experience. J Urol. 1992; 148 24-29
- 18 Kletscher B A, Qian J, Bostwick D G et al. Prospective analysis of multifocality in renal cell carcinoma: influence of histological pattern, grade, number, size, volume and deoxyribonucleic acid ploidy. J Urol. 1995; 153 904-906
- 19 Hafez K S, Fergany A F, Novick A C. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol. 1999; 162 1930-1933
- 20 Belldegrun A, Tsui K H, de Kernion J B et al. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-nodemetastasis staging system. J Clin Oncol. 1999; 17 2868-2875
- 21 Indudhara R, Bueschen A J, Urban D A et al. Nephron-sparing surgery compared with radical nephrectomy for renal tumors: current indications and results. South Med J. 1997; 90 982-985
- 22 Sobin L H, Wittekind C. TNM classification of malignant tumours. 6 edn. New York: Wiley-Liss; 2002
- 23 Kural A R, Demirkesen O, Onal B et al. Outcome of nephron sparing-surgery: elective versus imperative indications. Urol Int. 2003; 71 190-196
- 24 Grimaldi G, Reuter V, Russo P. Bilateral non-familial renal cell carcinoma. Ann Surg Oncol. 1998; 5 548-552
- 25 Siemer S, Uder M, Zell A et al. Bilateral kidney tumor: Therapy management and histopathological results with long-term follow-up of 66 patients. Urologe A. 2001; 40 114-120
- 26 Pahernik S, Cudovic D, Roos F et al. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes. BJU Int. 2007; 100 26-29
- 27 Patard J J, Shvarts O, Lam J S et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol. 2004; 171 2181-2185
- 28 Blute M L, Itano N B, Cheville J C et al. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. J Urol. 2003; 169 1276-1281
- 29 Ghavamian R, Cheville J C, Lohse C M et al. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. J Urol. 2002; 168 454-459
- 30 Saranchuk J W, Touijer A K, Hakimian P et al. Partial nephrectomy for patients with a solitary kidney: the Memorial Sloan-Kettering experience. BJU Int. 2002; 94 1323-1328
- 31 Pahernik S, Roos F, Wiesner C et al. Nephron sparing surgery for renal cell carcinoma in a solitary kidney. World J Urol. 2007; 25 513-517
- 32 Fergany A F, Saad I R, Woo L et al. Open partial nephrectomy for tumor in a solitary kidney: experience with 400 cases. J Urol. 2006; 175 1630-1633
- 33 Becker F, Siemer S, Humke U et al. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: long-term survival data of 216 patients. Eur Urol. 2006; 49 308-313
- 34 Permpongkosol S, Colombo Jr J R, Gill I S et al. Positive surgical parenchymal margin after laparoscopic partial nephrectomy for renal cell carcinoma: oncological outcomes. J Urol. 2006; 176 2401-2404
- 35 Ficarra V, Novara G, Galfano A et al. Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability?. Urology. 2004; 63 1050-1054
- 36 Leibovich B C, Blute M L, Cheville J C et al. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol. 2004; 171 1066-1070
- 37 Becker F, Siemer S, Hack M et al. Excellent long-term cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4 cm. Eur Urol. 2006; 49 1058-1063
- 38 Carini M, Minervini A, Lapini A et al. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival. J Urol. 2006; 175 2022-2026
- 39 Novick A C, Derweesh I. Open partial nephrectomy for renal tumors: current status. Br J Urol. 2005; 95 (S 2) 35-40
- 40 Pahernik S, Roos F, Röhrig B et al. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm. J Urol. 2008; 179 71-74
- 41 Thompson R H, Leibovich B C, Lohse C M et al. Complications of contemporary open nephron sparing surgery: a single institution experience. J Urol. 2005; 174 855-858
- 42 Steinbach F, Stockle M, Hohenfellner R. Clinical experience with nephron-sparing surgery in the presence of a normal contralateral kidney. Semin Urol Oncol. 1995; 13 288-291
- 43 Lau W K, Blute M L, Weaver A L et al. Matched comparison of radical nephrectomy vs nephron sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000; 75 1236-1242
- 44 Campbell S C, Novick A C, Streem S B et al. Complications of nephron-sparing surgery for renal tumors. J Urol. 1994; 151 1177-1180
- 45 Polascik T J, Pound C R, Meng M V et al. Partial nephrectomy: technique, complications and pathological findings. J Urol. 1995; 154 1312-1318
- 46 Duque J L, Loughlin K R, O’Leary M P et al. Partial nephrectomy: alternative treatment for selected patients with renal cell carcinoma. Urology. 1998; 52 584-590
- 47 Herr H W. Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-year followup. J Urol. 1999; 161 33-35
F. C. RoosM. D.
Department of Urology and Pediatric Urology · Johannes Gutenberg University
Langenbeckstraße 1
55101 Mainz
Germany
Phone: +49 / 61 31 / 1 71
Fax: +49 / 61 31 / 17 64 15
Email: frederik.roos@gmx.de